Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 24246063)

1.

Cost and time savings from a rapid access model of care using transient elastography to screen and triage patients with chronic Hepatitis C infection.

Whitty JA, Tallis C, Nguyen KH, Scuffham PA, Crosland P, Hewson K, Pai Mangalore R, Black M, Holtmann G.

J Med Econ. 2014 Feb;17(2):159-65. doi: 10.3111/13696998.2013.867271. Epub 2013 Dec 5.

PMID:
24246063
2.
3.

Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C.

Fraquelli M, Rigamonti C, Casazza G, Donato MF, Ronchi G, Conte D, Rumi M, Lampertico P, Colombo M.

J Hepatol. 2011 Apr;54(4):621-8. doi: 10.1016/j.jhep.2010.07.017. Epub 2010 Oct 1.

PMID:
21146243
4.

The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response.

D'Ambrosio R, Aghemo A, Fraquelli M, Rumi MG, Donato MF, Paradis V, Bedossa P, Colombo M.

J Hepatol. 2013 Aug;59(2):251-6. doi: 10.1016/j.jhep.2013.03.013. Epub 2013 Mar 23.

PMID:
23528378
5.

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy.

Backx M, Lewszuk A, White JR, Cole J, Sreedharan A, van Sanden S, Diels J, Lawson A, Neal KR, Wiselka MJ, Ito T, Irving WL.

J Viral Hepat. 2014 Mar;21(3):208-15. doi: 10.1111/jvh.12132. Epub 2013 Aug 1.

PMID:
24438682
6.

[Evaluation of the costs of transient elastography (FibroScan(®)) in the diagnosis of liver fibrosis in HIV patients with hepatitis C virus].

García-Jurado L, Oyagüez I, Casado MÁ, Tural C, González-García J, Ortega E, Pineda JA.

Enferm Infecc Microbiol Clin. 2012 Jun;30(6):294-9. doi: 10.1016/j.eimc.2011.11.004. Epub 2011 Dec 22. Spanish.

PMID:
22197275
7.

The spectrum of chronic hepatitis C virus infection in the Virginia Correctional System: development of a strategy for the evaluation and treatment of inmates with HCV.

Sterling RK, Brown RS Jr, Hofmann CM, Luketic VA, Stravitz RT, Sanyal AJ, Contos MJ, Mills AS, Smith V, Shiffman ML.

Am J Gastroenterol. 2005 Feb;100(2):313-21.

PMID:
15667488
8.

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

9.

Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.

Marshall M, Crowther R, Almaraz-Serrano A, Creed F, Sledge W, Kluiter H, Roberts C, Hill E, Wiersma D, Bond GR, Huxley P, Tyrer P.

Health Technol Assess. 2001;5(21):1-75. Review.

10.

Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C.

Cardoso AC, Carvalho-Filho RJ, Stern C, Dipumpo A, Giuily N, Ripault MP, Asselah T, Boyer N, Lada O, Castelnau C, Martinot-Peignoux M, Valla DC, Bedossa P, Marcellin P.

Liver Int. 2012 Apr;32(4):612-21. doi: 10.1111/j.1478-3231.2011.02660.x. Epub 2011 Nov 22.

PMID:
22103765
11.

Interferon alpha (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation.

Shepherd J, Jones J, Hartwell D, Davidson P, Price A, Waugh N.

Health Technol Assess. 2007 Mar;11(11):1-205, iii. Review.

12.

A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of 'PhysioDirect' telephone assessment and advice services for physiotherapy.

Salisbury C, Foster NE, Hopper C, Bishop A, Hollinghurst S, Coast J, Kaur S, Pearson J, Franchini A, Hall J, Grove S, Calnan M, Busby J, Montgomery AA.

Health Technol Assess. 2013 Jan;17(2):1-157, v-vi. doi: 10.3310/hta17020.

13.
14.

Home treatment for mental health problems: a systematic review.

Burns T, Knapp M, Catty J, Healey A, Henderson J, Watt H, Wright C.

Health Technol Assess. 2001;5(15):1-139. Review.

15.

[Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].

Della Palma P, Moresco L, Giorgi Rossi P.

Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 3):e1-43. Italian.

PMID:
23139174
16.

Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs.

Wong JB, Bennett WG, Koff RS, Pauker SG.

JAMA. 1998 Dec 23-30;280(24):2088-93.

PMID:
9875876
18.

Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population.

Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ.

JAMA. 2003 Jul 9;290(2):228-37.

PMID:
12851278
19.

Health care costs of a continuing epidemic of hepatitis C virus infection among injecting drug users.

Brown K, Crofts N.

Aust N Z J Public Health. 1998;22(3 Suppl):384-8.

PMID:
9629827
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk